March 2022 American National Drug and Alcohol Facts Week: Raising Awareness About the Link Between Alcohol and Liver Disease
February 2022 New Baveno VII Guidelines Further Validate FibroScan® for Management of Patients with Advanced Chronic Liver Disease
February 2022 American Heart Month: Battling the Epidemics of Cardiovascular Disease and Liver Disease
November 2021 Highlights from 2021 AASLD Liver Meeting: Early Detection and Monitoring with FibroScan® Mitigates Risk of Patients Developing Fibrosis/Cirrhosis
October 2021 Link Between Non-alcoholic Fatty Liver Disease, Obesity and Liver Cancer Calls for Early Detection and Monitoring
August 2021 New EASL Clinical Practice Guidelines Make Unprecedented Recommendation for Non-Invasive FibroScan® and Care Management
August 2021 Douglas Dieterich, M.D., discusses role of FibroScan® in the diagnoses of chronic liver disease
July 2021 Non-Invasive Liver Exam Identifies Asymptomatic Liver Disease, Provides Follow-Up for Hepatitis C Virus
FibroScan®
